| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.37 | 5e-13 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-07 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |